查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832183

動物遺傳學市場（按動物種類、技術、應用和最終用戶分類）—2025-2032 年全球預測

Animal Genetics Market by Animal Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物遺傳學市場將成長至 148.8 億美元，複合年成長率為 9.55%。

主要市場統計數據
基準年2024年 71.7億美元
預計2025年 78.4億美元
預測年份：2032年 148.8億美元
複合年成長率（%） 9.55%

簡要介紹影響現代動物遺傳學創新和產業決策的不斷發展的科學、商業、監管和道德格局

動物遺傳學領域如今在糧食安全、永續生產和轉化生物技術的交叉領域中佔據核心地位。分子工具和數據分析領域的科學進步正在加速遺傳變異的識別、檢驗和應用於育種計劃的速度。同時，商業公司和公共機構正面臨影響其部署軌蹟的複雜問題，包括倫理問題、不斷變化的法規以及相關人員不斷變化的期望。

本報告總結了當代影響動物遺傳學研究和商業化的促進因素，並強調了其對研究人員、育種者、政策制定者和投資者的實際意義。報告從技術能力、應用主導價值和機構採用模式等方面對該領域進行了概述。引言部分整合了實驗室創新、產品開發平臺和監管訊號的證據，幫助讀者了解該領域面臨的關​​鍵挑戰和機會。

讀者可以期待一種結合技術清晰度和戰略洞察力的平衡觀點，旨在為決策者提供一個框架，闡明科學前景與可行實施之間的一致性，其中最大的障礙仍然存在，以及可以在不同的組織目標中創造永續優勢的近期行動。

技術、監管和商業性趨勢的綜合視角正在從結構上再形成動物遺傳學創新從實驗室走向大規模部署的方式

在精準生物學、計算分析和相關人員影響力的共同推動下，動物遺傳學領域正經歷一場變革性轉變。基因編輯工具日益複雜化和普及化，使得先前僅停留在理論層面的針對性干預措施成為可能。同時，基因組選擇和高通量表現型分析正在將海量資料集轉化為持續可操作的育種決策。這些技術變革，加上育種技術和資料基礎設施的改進，正在縮短轉換時間並降低單位開發成本。

同時，社會和監管因素正在重塑部署策略。公眾對基因介入的審查、對動物福利日益成長的擔憂以及對透明度的不斷提升的期望，促使上市公司和機構設計優先考慮可追溯性、嚴格的安全評估和有意義的相關人員參與的途徑。有些國家正在尋求建立一個能夠負責任地管理基因編輯的框架，而有些國家則強調預防。這種監管異質性正在推動跨市場的策略性細分，而敏捷的組織正在投資能夠適應不同核准途徑的模組化開發計劃。

商業性，技術發起者、商業育種者和產品整合商之間的夥伴關係正成為擴大規模的主導模式。垂直整合和聯盟式合作正成為共用開發風險、匯集專業知識和加速終端用戶獲取的可行方式。總而言之，這些趨勢不僅代表遺傳科學從實驗室示範走向動物群體實用化的漸進式轉型，更代表結構性的重建。

美國近期的2025年關稅調整如何加速供應鏈區域化，並導致採購、夥伴關係和國內產能建置的策略轉變

貿易政策和關稅制度的變化可能會對供應鏈的邏輯、採購決策以及跨境研究合作的經濟效益帶來重大變化。 2025年，美國實施了累積關稅調整，為基因輸入、序列測定設備和專用試劑的國際供應商以及依賴進口基因材料和基因編輯平台的公司帶來了新的考量。這些政策發展凸顯了在地化供應彈性的重要性，並促使相關人員重新評估籌資策略和區域夥伴關係。

因此，許多公司採取了以下措施：多元化供應商網路、擴大區域生產能力，並加快替代供應商的資格審核，以減少對單一來源的依賴。研究合作和測試流程也調整了計劃，以應對潛在的海關延誤和增加的文件要求。對於進口遺傳材料或依賴跨境育種品質交換的育種項目而言，海關環境帶來了額外的行政複雜性和成本壓力，影響了營運的優先順序。

重要的是，這些政策轉變重新引發了關於國內能力建構的討論。公共和私營相關人員紛紛支持本地基礎設施投資，從低溫保存設施到定序和生物資訊平台，以保持策略自主權並保障育種時間表。雖然關稅並沒有改變基礎科學潛力，但它確實成為區域化和供應鏈現代化策略的催化劑。

一個策略性細分框架，將動物物種、實行技術、應用優先順序和最終用戶動機結合起來，以指導投資和發展決策

細緻的細分觀點能夠清楚闡明生物機會與商業性途徑和監管摩擦之間的對應關係。就動物物種而言，研究和應用涵蓋水產養殖、家牛、家禽和豬，其中家牛進一步細分為具有不同繁殖目標、生產限制和價值驅動力的肉牛和酪農企業。這種物種差異會影響技術優先順序和最終用戶參與度，因為高通量水產養殖計畫與多代肉牛牛群的生物目標、繁殖週期和經濟獎勵有顯著差異。

從技術角度來看，克隆、基因編輯、基因組選擇和標記輔助選擇目前在該領域以互補的方式部署。在基因編輯領域，CRISPR/Cas9、TALEN 和 ZFN 等技術在精確度、易實施性和監管核准方面各有優劣，這些技術屬性顯示哪些工具更適合特定途徑的目標。由於同一基因組工具可能根據實驗設計和檢驗策略針對抗病性、飼料效率、生育力、生長率或產乳量進行最佳化，因此根據應用需求選擇合適的技術至關重要。

應用主導的細分顯示，抗病性和飼料效率等目標通常透過降低生產風險和投入成本來提供跨產業價值，而生育率、生長率和產奶量則與特定品種的商業性目標密切相關。最終用戶包括學術機構、商業育種者、政府機構、製藥公司和研究機構，每個群體都為開發項目帶來不同的獎勵、營運節奏和風險接受度。此細分框架提供了一個實用的視角，可用於確定投資優先順序、設計檢驗路徑，以及將創新轉化為常規實踐所需參與的相關人員。

區域分析揭示了美洲、歐洲、中東和非洲以及亞太地區的政策制度、能力水準和商業結構如何變化，從而影響採用和擴大規模的途徑

區域動態顯著影響基因創新的監管、資助和應用方式。在美洲，強勁的私人投資、一體化的價值鏈和廣泛的商業育種基礎設施創造了良好的環境，一旦監管明確，轉化研究就能迅速擴大規模。北美和南美市場擁有不同的消費者偏好和政策框架，這反過來又影響技術部署和產業合作的速度和模式。

歐洲、中東和非洲呈現出不同的監管理念和能力水準。在歐洲地區，通常高度重視預防措施、可追溯性和廣泛的相關人員諮詢，這些因素會影響產品設計和傳播策略。相較之下，中東和非洲部分地區則優先考慮透過公共投資和國際夥伴關係支持的有針對性的育種計畫來快速提高生產力。解決這些地區差異需要採取適應性的監管策略和與當地相關的示範計劃，以建立信譽並獲得企業認可。

亞太地區雖然差異巨大，但也存在通用，包括政府主導的強大研發重點、數位農業工具的快速應用以及集約化的工業規模水產養殖和畜牧生產。該地區各國正在投資基因組基礎設施和公私合營關係，以應對糧食安全和出口競爭力問題。總體而言，區域差異凸顯了根據每個地理區域獨特的社會政治和經濟現實，量身定做開發平臺、監管參與和相關人員拓展的重要性。

深入了解企業策略、夥伴關係和能力整合，這將決定哪些組織能夠有效地將遺傳學創新轉化為可擴展的商業性解決方案

動物遺傳學領域的公司和組織的行為日益體現出科學專業化與平台整合的整合。擁有強大知識產權組合、可擴展實驗室工作流程和監管專業知識的技術提供者正將自己定位為下游育種和商業化的推動者。許多組織正在推行雙重策略：一方面自主開發核心平台能力，另一方面與商業育種者和研究機構合作進行實地檢驗和推廣。

策略聯盟十分常見，技術發起者與育種公司合作，將基因組解決方案整合到現有研發管線中，而合約研究機構和服務實驗室則為檢測標準化和監管文件提供支援。對專有數據資產和表現型關聯基因組資料庫的投資已成為競爭優勢，為模型準確性和產品可預測性奠定了基礎。同時，重視透明檢驗、第三方複製和監管參與的公司可以降低上市時間風險，並增強相關人員的信心。

併購仍然是獲取能力的重要途徑，尤其是在企業尋求將分子套件與動物育種專業知識相結合，或獲取區域重要育種性狀或分銷管道的情況下。在整個生態系統中，成功的企業能夠平衡科學卓越性與切合實際的商業化路徑，投資於監管和道德管治，並保持靈活的夥伴關係模式，以便在技術和市場訊號一致時快速擴張。

可操作的、實用的建議，以協調技術優先、管治、供應彈性和資料能力，從而加速負責任的部署和商業性成功

產業領導者應採取投資組合策略，平衡短期營運收益與長期平台建置。優先考慮針對高影響力應用的計劃，例如抗病性和飼料效率，因為這些目標通常能為生產者帶來明確、可衡量的效益，同時也能即時降低生產風險和投入成本。此外，還應選擇性地投資於提高生育力和產奶量，透過品種穩定性和長期基因管理，在多個週期內放大回報。

管治和相關人員的參與同樣重要。建立透明的檢驗流程，盡可能發布重複研究，並在獲得可接受證據的閾值與監管機構溝通。積極設計動物福利評估和公共關係策略，以建立社會許可。在營運方面，要多元化供應商關係，確定區域生產和定序能力，並結合情境規劃來應對政策和貿易干擾。利用與學術和研究機構的夥伴關係關係，獲取專業知識並分擔檢驗負擔。

最後，投資數據基礎設施和人力資本。高品質的表現型關聯基因組資料庫、可互通的分析平台以及高技能的跨學科團隊，對於將實驗室創新轉化為可重複的現場成果至關重要。透過將科學嚴謹性與靈活的商業化計劃和強力的相關人員參與相結合，行業領導者可以加速負責任的部署，同時管理風險並提升長期價值創造。

結合專家訪談、文獻綜合、專利和政策審查以及情境分析的嚴格混合方法研究途徑提供了檢驗的產業見解

該調查方法結合了定性和定量證據流，對動物遺傳學領域進行了穩健且可複製的分析。主要研究包括對專家、育種者、監管專業人員和研發人員的結構化訪談，以了解營運現狀、策略重點以及已發表文獻中未提及的痛點。此外，還舉辦了研討會和專家小組討論，以檢驗新的假設並完善情境假設。

二次研究系統地回顧了同行評審文獻、專利申請、監管指導文件和技術白皮書，以繪製技術發展軌跡並識別有效的用例。此外，比較政策分析探討了各轄區在基因編輯、可追溯性和動物福利方面的做法，並提供了特定地區的建議。數據合成利用了主要見解與記錄證據的交叉檢驗，並透過情境分析對研究結果進行壓力測試，以探索可行的政策和市場發展。

最後，我們透過反覆檢驗以及透明地記錄資料來源和分析假設，確保了調查方法和資料來源的嚴謹性。對於存在不確定性的情況，我們運用保守推理原則，並說明其他解釋，以幫助讀者評估風險及其在自身決策情境中的適用性。

簡要總結結論，平衡動物遺傳學的科學前景與監管、檢驗和相關人員接受的實際考慮。

現代動物遺傳學生態系統蘊含著巨大的機遇，但也受到複雜的監管、倫理和營運限制的限制。基因編輯、基因組選擇和先進育種方法等技術工具提供了精準的槓桿，可以提高抗病性、飼料效率、繁殖力、生長率和產乳量。然而，大規模應用取決於科學檢驗、監管認可、供應鏈韌性以及相關人員信任之間的協調。

策略差異化將來自那些將卓越的科學成果與靈活的商業化策略相結合的組織——這些組織投資於高品質的表現型相關數據，設計嚴格透明的檢驗方案，並建立連接實驗室創新和現場應用的夥伴關係關係。區域政策多樣性和不斷變化的貿易環境需要靈活的計劃，這些計劃既能適應本地情況，又能保持全球互通性。透過優先考慮可降低生產風險的應用，並建立能夠預見社會關切的管治，相關人員可以負責任地加速轉換進程。

總而言之，該領域正在從探索性研究轉向實用且可部署的干涉措施。未來的道路強調實用科學、嚴謹的檢驗以及與監管機構和公眾的積極互動，以確保基因創新在生產、健康和永續性目標方面帶來持久的效益。

目錄

第1章 引言

第2章分析方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合CRISPR鹼基編輯技術，提升牲畜抗病能力與生產力
  • 應用表觀遺傳標記預測極端氣候條件下乳牛的耐熱性
  • 利用機器學習驅動的基因組選擇演算法加速豬隻生長性狀發育
  • 開發結合總體基因體學學和宿主基因組學的多體學方法來改善家禽腸道健康和性能
  • 透過先進的基因組分析擴大精準育種計劃，減少反芻動物甲烷排放
  • 利用 CRISPR 基因編輯技術將多個有益等位基因引入栽培物種，以增強抗病能力
  • 實施基於區塊鏈的基因組數據共用平台，確保全球畜牧業實踐的可追溯性
  • 將人工智慧融入表現型組學，實現牲畜高通量性狀測量和分析的自動化

第6章：美國關稅的累積影響（2025年）

第7章：人工智慧（AI）的累積影響（2025年）

第 8 章：動物遺傳學市場（按動物類型）

  • 水產養殖
  • 牛
    • 肉牛
    • 乳牛
  • 家禽
  • 豬

9. 動物遺傳學市場（按技術）

  • 複製
  • 基因編輯
    • CRISPR/Cas9
    • TALEN
    • ZFN
  • 基因組選擇
  • 標記輔助選擇

第 10 章：動物遺傳學市場（按應用）

  • 抗病性
  • 飼料效率
  • 生育能力
  • 成長率
  • 牛奶產量

第 11 章動物遺傳學市場（按最終用戶）

  • 學術機構
  • 商業育種者
  • 政府機構
  • 製藥公司
  • 研究所

第 12 章：按地區分類的動物遺傳學市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：動物遺傳學市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按國家/地區分類的動物遺傳學市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 市佔率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭情境分析
    • Genus plc
    • Hendrix Genetics NV
    • Topigs Norsvin Holding AS
    • Aviagen International, Inc.
    • Neogen Corporation
    • Zoetis Inc.
    • CRV BV
    • STgenetics, Inc.
    • Genesus Inc.
    • Lohmann Tierzucht GmbH
Product Code: MRR-4358BACA7E12

The Animal Genetics Market is projected to grow by USD 14.88 billion at a CAGR of 9.55% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.17 billion
Estimated Year [2025] USD 7.84 billion
Forecast Year [2032] USD 14.88 billion
CAGR (%) 9.55%

A concise introduction outlining the evolving scientific, commercial, regulatory, and ethical landscape shaping modern animal genetics innovation and industry decision-making

The field of animal genetics now occupies a central role at the intersection of food security, sustainable production, and translational biotechnology. Scientific advances in molecular tools and data analytics have accelerated the pace at which genetic variation can be identified, validated, and applied to breeding programs. At the same time, commercial players and public institutions confront a complex web of ethical questions, evolving regulation, and shifting stakeholder expectations that shape deployment pathways.

This report synthesizes the contemporary drivers shaping animal genetics research and commercialization, emphasizing the practical implications for researchers, breeders, policy makers, and investors. It frames the sector in terms of technological capability, application-driven value, and institutional adoption patterns. By integrating evidence from laboratory innovations, product development pipelines, and regulatory signals, the introduction grounds readers in the landscape's critical tensions and opportunities.

Readers should expect a balanced perspective that pairs technical clarity with strategic insight. The goal is to equip decision-makers with a framework that clarifies where scientific promise aligns with feasible implementation, where barriers remain most material, and where near-term actions can create durable advantage across diverse organizational objectives.

An integrated view of converging technological, regulatory, and commercial trends that are structurally reshaping how animal genetics innovations progress from lab to large-scale deployment

The animal genetics landscape is in the midst of transformative shifts driven by converging advances in precision biology, computational analytics, and stakeholder influence. Gene editing tools, increasingly refined and democratized, are enabling targeted interventions that were previously theoretical, while genomic selection and high-throughput phenotyping are turning large datasets into consistently actionable breeding decisions. These technological shifts are complemented by improvements in reproductive technologies and data infrastructure that together compress translational timelines and lower per-unit development costs.

Concurrently, societal and regulatory vectors are reshaping deployment strategies. Public scrutiny of genetic interventions, elevated attention to animal welfare, and heightened expectations for transparency are prompting companies and institutions to design pathways that prioritize traceability, rigorous safety assessment, and meaningful stakeholder engagement. Policy environments are also evolving; some jurisdictions pursue enabling frameworks for responsibly managed gene editing, while others emphasize precaution. This regulatory heterogeneity is catalyzing strategic segmentation across markets, with agile organizations investing in modular development plans that can be adapted to divergent approval pathways.

Commercially, partnerships between technology originators, commercial breeders, and product integrators are becoming the predominant model for scaling. Vertical integration and consortium-style collaborations are emerging as pragmatic ways to share development risk, consolidate expertise, and accelerate access to end users. Taken together, these trends are not merely incremental; they represent a structural reconfiguration of how genetic science moves from laboratory proofs to operational use in animal populations.

How recent United States tariff adjustments in 2025 accelerated supply-chain regionalization and strategic shifts across procurement, partnerships, and domestic capacity building

Changes in trade policy and tariff regimes can produce material shifts in supply chain logic, sourcing decisions, and the economics of cross-border research collaborations. In 2025, cumulative tariff adjustments in the United States introduced new considerations for international suppliers of genetic inputs, sequencing equipment, and specialized reagents, as well as for firms that rely on imported genetic materials or gene-editing platforms. These policy moves have amplified the importance of localized supply resilience and have prompted stakeholders to re-evaluate procurement strategies and partnership geographies.

As a result, many firms responded by diversifying supplier networks, expanding regional manufacturing capacity, and accelerating qualification of alternative vendors to reduce single-source dependencies. Research collaborations and trial pipelines adjusted timelines to account for possible customs delays and increased documentation requirements. For breeding programs that import genetic material or rely on cross-border exchange of germplasm, the tariff environment created additional administrative complexity and incremental cost pressure that affected operational prioritization.

Importantly, these policy shifts also reanimated discussions about domestic capability building. Public and private actors moved to support local infrastructure investments, from cryopreservation facilities to sequencing and bioinformatics platforms, in order to preserve strategic autonomy and protect breeding timelines. While tariffs did not change the underlying scientific potential, they acted as an accelerant for regionalization and supply-chain modernization strategies which will continue to influence project design and partnership choices going forward.

A strategic segmentation framework that aligns animal types, enabling technologies, application priorities, and end-user motivations to guide investment and development decisions

A nuanced segmentation view clarifies where biological opportunity aligns with commercial pathways and regulatory friction. When considering animal type, research and applications span aquaculture, cattle, poultry, and swine, with cattle further differentiated into beef and dairy enterprises that have distinct breeding objectives, production constraints, and value drivers. These animal-type distinctions influence prioritization of technologies and end-user engagement because the biological targets, breeding cycles, and economic incentives differ markedly between, for example, a high-throughput aquaculture program and a multi-generational beef cattle herd.

From a technology standpoint, the sector now deploys cloning, gene editing, genomic selection, and marker assisted selection in complementary ways. Within gene editing, techniques such as CRISPR/Cas9, TALEN, and ZFN present different trade-offs of precision, ease of adoption, and regulatory recognition, and these technical attributes inform which tools are suitable for pathway-specific goals. Aligning technology choice with application needs is crucial because the same genomic tool can be optimized for disease resistance, feed efficiency, fertility, growth rate, or milk production depending on experimental design and validation strategy.

Application-driven segmentation reveals that objectives like disease resistance and feed efficiency often deliver cross-sector value by reducing production risk and input costs, while fertility, growth rate, and milk production are tightly linked to breed-specific commercial objectives. End users encompass academic institutes, commercial breeders, government agencies, pharmaceutical companies, and research institutes, and each group brings different incentives, operational tempos, and risk tolerances to development programs. Taken together, this segmentation framework provides a practical lens to prioritize investments, design validation pathways, and map the stakeholders that must be engaged to move innovations into routine practice.

A regional analysis revealing how divergent policy regimes, capacity levels, and commercial structures across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and scale-up pathways

Regional dynamics materially influence how genetic innovations are regulated, funded, and adopted. In the Americas, strong private-sector investment, integrated value chains, and a large commercial breeding infrastructure create an environment where translational work can scale quickly once regulatory clarity is achieved. North and South American markets present differentiated consumer preferences and policy frameworks, which in turn shape the pace and modalities of technology deployment and industry collaboration.

Europe, the Middle East, and Africa present a mosaic of regulatory philosophies and capacity levels. The European sphere often emphasizes precaution, traceability, and extensive stakeholder consultation, which influences product design and communications strategy. By contrast, parts of the Middle East and Africa are prioritizing rapid productivity gains through targeted breeding initiatives, often supported by public investment and international partnerships. These regional differences necessitate adaptive regulatory strategies and locally relevant demonstration projects to build credibility and operational buy-in.

Asia-Pacific reflects high heterogeneity but shares common features of strong government-led R&D priorities, rapid adoption of digital agricultural tools, and concentrated pockets of industrial-scale aquaculture and livestock production. Countries in this region are investing in genomic infrastructure and public-private collaborations to address food security and export competitiveness. Collectively, regional variation underscores the importance of tailoring development pipelines, regulatory engagement, and stakeholder outreach to the specific socio-political and economic realities of each geographic context.

Insight into corporate strategies, partnerships, and capability consolidation that determine which organizations effectively translate genetics innovations into scalable commercial solutions

Corporate and institutional behavior in animal genetics increasingly reflects a blend of scientific specialization and platform consolidation. Technology providers that combine robust intellectual property portfolios with scalable laboratory workflows and regulatory expertise are positioned to act as enablers for downstream breeding and productization. Many organizations pursue a dual strategy of in-house development for core platform capabilities while partnering with commercial breeders and research institutes for field validation and distribution.

Strategic alliances are a common pattern: technology originators collaborate with breeding companies to integrate genomic solutions into existing pipelines, while contract research organizations and service laboratories offer assay standardization and regulatory dossier support. Investment in proprietary data assets and phenotype-linked genomic databases has emerged as a competitive differentiator because it underpins model accuracy and product predictability. At the same time, companies that prioritize transparent validation, third-party replication, and engagement with regulatory authorities reduce time-to-market risk and enhance stakeholder trust.

Mergers and acquisitions remain an important avenue for capability acquisition, particularly where firms seek to combine molecular toolkits with animal breeding expertise or to secure access to regionally important germplasm and distribution channels. Across the ecosystem, successful companies balance scientific excellence with pragmatic commercialization pathways, invest in regulatory and ethical governance, and maintain flexible partnership models that permit rapid scaling when technical and market signals align.

Actionable and practical recommendations that align technology prioritization, governance, supply resilience, and data capabilities to accelerate responsible deployment and commercial success

Industry leaders should pursue a portfolio approach that balances near-term operational gains with longer-term platform creation. Prioritize projects that address high-impact applications such as disease resistance and feed efficiency because these objectives often yield immediate reductions in production risk and input costs while providing clear, measurable benefits to producers. Complement these efforts with selective investments in fertility and milk production improvements where breed stability and long-term genetic stewardship can amplify returns over multiple cycles.

Governance and stakeholder engagement are equally important. Establish transparent validation pipelines, publish replication studies where feasible, and engage with regulators early to align on acceptable evidence thresholds. Proactively design animal welfare assessments and public communication strategies to build social license. From an operational perspective, diversify supplier relationships, qualify regional manufacturing and sequencing capacity, and embed scenario planning to absorb policy or trade disruptions. Leverage partnerships with academic institutes and research organizations to access specialized expertise and to share validation burden.

Finally, invest in data infrastructure and human capital. High-quality phenotype-linked genomic databases, interoperable analytics platforms, and skilled multidisciplinary teams are essential to convert laboratory innovations into reproducible field outcomes. By integrating scientific rigor with adaptive commercialization plans and robust stakeholder engagement, industry leaders can accelerate responsible deployment while managing risk and enhancing long-term value creation.

A rigorous mixed-methods research approach combining expert interviews, literature synthesis, patent and policy review, and scenario analysis to produce validated industry insights

The research methodology combines qualitative and quantitative evidence streams to produce a robust, reproducible analysis of the animal genetics landscape. Primary research included structured interviews with domain experts, breeders, regulatory specialists, and technology developers to capture operational realities, strategic priorities, and pain points that are not visible in published literature. These interviews were complemented by targeted workshops and expert panels that validated emerging hypotheses and refined scenario assumptions.

Secondary research incorporated a systematic review of peer-reviewed literature, patent filings, regulatory guidance documents, and technical whitepapers to map technological trajectories and identify validated use cases. In addition, comparative policy analysis examined jurisdictional approaches to gene editing, traceability, and animal welfare to inform region-specific recommendations. Data synthesis leveraged cross-validation between primary insights and documented evidence, and findings were stress-tested through scenario analysis to explore plausible policy and market evolutions.

Finally, methodological rigor was maintained through iterative validation steps and transparent documentation of data sources and analytical assumptions. Where uncertainty remained, conservative inference principles were applied and alternative interpretations were described to ensure readers can assess risk and applicability to their own decision contexts.

A concise concluding synthesis that balances the scientific promise of animal genetics with pragmatic considerations for regulation, validation, and stakeholder acceptance

The contemporary animal genetics ecosystem presents significant opportunities tempered by complex regulatory, ethical, and operational constraints. Technological tools such as gene editing, genomic selection, and advanced reproductive methods provide precise levers to improve disease resistance, feed efficiency, fertility, growth rate, and milk production. However, adoption at scale depends on alignment between scientific validation, regulatory acceptance, supply-chain resilience, and stakeholder trust.

Strategic differentiation will come from organizations that integrate scientific excellence with adaptive commercialization strategies: those that invest in high-quality phenotype-linked data, design rigorous and transparent validation programs, and cultivate partnerships that bridge laboratory innovation with field implementation. Regional policy diversity and evolving trade environments demand flexible plans that can be localized while preserving global interoperability. By prioritizing applications that reduce production risk and by building governance practices that anticipate societal concerns, stakeholders can responsibly accelerate translational progress.

In sum, the sector is moving from exploratory research toward practical, deployable interventions. The path forward emphasizes pragmatic science, robust validation, and proactive engagement with regulators and the public to ensure genetic innovations deliver durable benefits across production, health, and sustainability objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of CRISPR base editing technologies to enhance livestock disease resistance and productivity
  • 5.2. Application of epigenetic markers to predict heat tolerance in dairy cattle under extreme climate conditions
  • 5.3. Use of genomic selection algorithms powered by machine learning to accelerate swine growth trait development
  • 5.4. Development of multiomics approaches combining metagenomics and host genomics to improve poultry gut health and performance
  • 5.5. Expansion of precision breeding programs targeting methane emission reduction in ruminants through advanced genomic assays
  • 5.6. Adoption of CRISPR prime editing to introduce multiple beneficial alleles in aquaculture species for enhanced disease resilience
  • 5.7. Implementation of blockchain-enabled genomic data sharing platforms to ensure traceability in global animal breeding practices
  • 5.8. Integration of artificial intelligence in phenomics to automate high-throughput trait measurement and analysis in livestock

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Genetics Market, by Animal Type

  • 8.1. Aquaculture
  • 8.2. Cattle
    • 8.2.1. Beef Cattle
    • 8.2.2. Dairy Cattle
  • 8.3. Poultry
  • 8.4. Swine

9. Animal Genetics Market, by Technology

  • 9.1. Cloning
  • 9.2. Gene Editing
    • 9.2.1. CRISPR/Cas9
    • 9.2.2. TALEN
    • 9.2.3. ZFN
  • 9.3. Genomic Selection
  • 9.4. Marker Assisted Selection

10. Animal Genetics Market, by Application

  • 10.1. Disease Resistance
  • 10.2. Feed Efficiency
  • 10.3. Fertility
  • 10.4. Growth Rate
  • 10.5. Milk Production

11. Animal Genetics Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Commercial Breeders
  • 11.3. Government Agencies
  • 11.4. Pharmaceutical Companies
  • 11.5. Research Institutes

12. Animal Genetics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Animal Genetics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Animal Genetics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Genus plc
    • 15.3.2. Hendrix Genetics N.V.
    • 15.3.3. Topigs Norsvin Holding A.S.
    • 15.3.4. Aviagen International, Inc.
    • 15.3.5. Neogen Corporation
    • 15.3.6. Zoetis Inc.
    • 15.3.7. CRV B.V.
    • 15.3.8. STgenetics, Inc.
    • 15.3.9. Genesus Inc.
    • 15.3.10. Lohmann Tierzucht GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ANIMAL GENETICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ANIMAL GENETICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL GENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL GENETICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GENETICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. GCC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. GCC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 294. GCC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 295. GCC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. GCC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. GCC ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. GCC ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 336. G7 ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 337. G7 ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. G7 ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. G7 ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. G7 ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 342. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 343. NATO ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. NATO ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. NATO ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 346. NATO ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 347. NATO ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 348. NATO ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 349. NATO ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 350. NATO ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 351. NATO ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. NATO ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. NATO ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 354. NATO ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 355. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)

TABLE